Results

Total Results: 1,170 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

341. Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non–ST Elevation Myocardial Infarction | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/angina-heart-attack-treatments/research
     November 04, 2013 - Structured Abstract Objectives For patients with unstable angina or non–ST elevation myocardial infarction … Patients undergoing an early invasive approach Upstream (precatheterization) treatment using glycoprotein … Patients undergoing an initial conservative approach In randomized trials, enoxaparin reduced composite … Further study is needed to determine the effectiveness and safety of newer agents in combination with … with diabetes, women, obese patients, and people with comorbid illness).

342. CARDIOVASCULAR (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cardiovascular-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - However, some noted insufficient information regarding long-term safety and efficacy. … ; a long-term patient registry to determine long- term safety; and an enhanced pharmacovigilance program … could affect physician and patient acceptance. … Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous … Another trick to improve the safety of transseptal puncture.

343. Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/breast-cancer-imaging/research-protocol
     December 17, 2013 - the accuracy, benefits and potential risks of each modality, including sensitivity and specificity, safety … What are the advantages (e.g., sensitivity and specificity) and disadvantages (e.g., safety issues, cost … Input from Key Informants will also be sought to determine safety issues that may be associated with … ; (b) health insurance policies; (c) patient preferences. … Patient Advocates [n=3] What factors are most important to patients regarding imaging following

344. breast-cancer-imaging-protocol-131217 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_research-protocol.pdf
     December 17, 2013 - • What are the advantages (e.g., sensitivity and specificity) and disadvantages (e.g., safety issues … patients with metastatic breast cancer. … Input from Key Informants will also be sought to determine safety issues that may be associated with … ; (b) health insurance policies; (c) patient preferences. … Patient Advocates [n=3] 1.

345. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - They were especially concerned about patient motivation to use this system and thought the patients … Despite the safety and efficacy of emergency contraception (EC), its use remains low. … Despite its safety and efficacy, EC use remains low.4 Barriers to use include lack of knowledge or … Overall, experts concluded that despite these obstacles, the potential for adoption by both patients … for this intervention to disrupt care processes and patient management.

346. S116 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s116.pdf
     October 01, 2007 - For the IV to be defined for each patient, we excluded each physician’s first patient from the cohort … These patients were treated by 6390 physicians. … Characteristics of Cohort Patient Characteristics N % Female patient 12,545 81.5 Age �80 10,750 70.0 … Indeed, in a comparative safety study of APMs in a population of seniors in British Columbia, Canada, … 0.78 �0.58, 1.02� 0.07 Patient of PCPs 0.98 �0.70, 1.39� 0.93 Long-acting benzodiazepines All patients

347. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - calibrating the CGM (where applicable) and checking sensor performance as needed plus associated reagents … with T1DM, longer safety and efficacy studies are needed before they can properly determine whether … moderately high potential for impact on the health care system, provided additional efficacy and safety … In terms of patient acceptance, this same expert conceded patients could be willing to accept the risk … Efficacy and safety of exenatide once weekly versus liraglutide in subjects with type 2 diabetes

348. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - calibrating the CGM (where applicable) and checking sensor performance as needed plus associated reagents … with T1DM, longer safety and efficacy studies are needed before they can properly determine whether … moderately high potential for impact on the health care system, provided additional efficacy and safety … In terms of patient acceptance, this same expert conceded patients could be willing to accept the risk … Efficacy and safety of exenatide once weekly versus liraglutide in subjects with type 2 diabetes

349. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-5-protocol-update-2023.pdf
     January 01, 2023 - reporting; (4) serve as a source for clinicians seeking information on effectiveness of interventions for patients … meditation or "mind body" or mindfulness or music or "prolonged exposure" or relaxation or "seeking safety … meditation or "mind body" or mindfulness or music or "prolonged exposure" or relaxation or "seeking safety … Allowed PTSD psychotherapy, other psychotherapy, and psychotropic medication indicators 12. … Patients with suicidality excluded indicator 13.

350. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
     April 01, 2012 - In a clinical trial, the effectiveness and safety of BT versus a sham procedure in patients (n = 288) … Thermoplasty System for treatment-resistant asthma studies to investigate the system’s long-term safety … Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter … PMA P080032: FDA summary of safety and effectiveness data (SSED) for the Alair bronchial thermoplasty … Safety of bronchial thermoplasty out to 5 years in patients with severe refractory asthma: research

351. Ch 2-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_2-user-guide-to-ocer_130129.pdf
     January 01, 2011 - Selecting the appropriate data source, patient population, inclusion/exclusion criteria, and comparators … deemed plausible only for unintended (usually adverse) effects of medical interventions, that is, for safety … The design was originally proposed for rare adverse events in vaccine safety studies for which it seems … Comparing different treatment options for a given patient (i.e., the same indication) is at the very … Control without separate controls: evaluation of vaccine safety using case-only methods.

352. DEcIDE 32: The Incident User Design in Comparative Effectiveness Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
     May 01, 2012 - about the outcomes, clinical effectiveness, safety, and appropriateness of health care items and services … When investigators know that a patient has used the intervention before the window chosen to define … Pharmacoepidemiol Drug Safety 2007;16:329-36. 4. Ray WA. … Pharmacoepidemiol Drug Safety 2006;15:81-92. 15. UKPDS Group. … Pharmacoepidemiol Drug Safety 2004;13:695-702. 19. Hippisley-Cox J, Coupland C.

353. Progestogens for the Prevention of Preterm Birth | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/progestogens-preterm-birth/research-protocol
     April 15, 2010 - associated with preterm birth represent untold distress for families, as well as significant costs to patients … 17-OHP treatment regimen is relatively modest; one study estimates it to be about $400 per treated patient … Adherence is influenced by the timing, dose, route, and interval of the progestogen given, patient factors … Adverse events may occur at any point after the treatment is received, and are affected by patient factors … factors such as specialty, and health care system factors such as cost and availability, as well as patient

354. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/progestogens-preterm-birth_research-protocol.pdf
     June 01, 2010 - associated with preterm birth represent untold distress for families, as well as significant costs to patients … 17-OHP treatment regimen is relatively modest; one study estimates it to be about $400 per treated patient … Adherence is influenced by the timing, dose, route, and interval of the progestogen given, patient factors … Adverse events may occur at any point after the treatment is received, and are affected by patient factors … factors such as specialty, and health care system factors such as cost and availability, as well as patient

355. Disposition of Comments for Psychological Treatments and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adult-treatment_disposition-comments.pdf
     April 03, 2013 - Or do some patients have major benefit on outcome X, and other patients on outcome Y? … …" a) Seeking Safety (SS) was designed for both genders. … The relevant paragraph was (and still is) in the Seeking Safety results section titled Prevention … We agree that this study has some limitations that limit what we can conclude about seeking safety … We also changed it to “seeking safety” rather than “safety seeking” to be consistent with wording

356. Anxiety in Children | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/anxiety-children/research-protocol
     September 13, 2016 - There is a great deal of uncertainty regarding comparative effectiveness and safety of all treatments … that are widely available and validated; which are:(patients/parent reported and clinician assessed), … What are the treatment burdens (for patients, providers, and health systems) and contextual factors ( … disorder, or separation anxiety Animals Adults (age ≥ 18 years) Infants (age < 3 years) Patients … Evidence-Based Treatments for Children and Adolescents: An Updated Review of Indicators of Efficacy and

357. Evaluation of Mental Health Mobile Applications (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/mental-health-app-draft-technical-brief.pdf
     June 21, 2021 - engagement in services, therapeutic relationships between clients and providers, and treatment retention … personalized medicine approach to mental health apps (i.e., will a specific app work for my specific client … receive an alert about their patient's health, or they may be able to access the patient’s health indicators … personalized medicine approach to mental health apps (i.e., will a specific app work for a specific client … Key substance use and mental health indicators in the United States: Results from the 2019 National

358. Anxiety in Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/anxiety-children_research-protocol.pdf
     September 12, 2016 - There is a great deal of uncertainty regarding comparative effectiveness and safety of all treatments … that are widely available and validated; which are:(patients/parent reported and clinician assessed … What are the treatment burdens (for patients, providers, and health systems) and contextual factors … specific phobias, generalized • Animals • Adults (age >= 18 years) • Infants (age < 3 years) • Patients … Evidence-Based Treatments for Children and Adolescents: An Updated Review of Indicators of Efficacy

359. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
     September 01, 2011 - How do the efficacy, effectiveness, safety, and adverse effects of treatment with DMARDs differ among … How do the efficacy, effectiveness, Insufficient Only one study—an RCT of methotrexate versus safety, … In addition, patient-level meta-analysis may help address this challenge. … • The need for study populations who are representative of typical patients with JIA. … Randomized discontinuation trials have helped to define the risk of flare in patients who respond to

360. Research Protocol: Radiation Therapy for Brain Metastases (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiation-therapy-brain-metases-protocol.pdf
     October 10, 2019 - Do adverse effects vary by important patient characteristics (i.e., age, performance status, patient … The draft protocol is informed by key informants representing patients, care givers, patient advocates … Safety of cranial radiotherapy concurrent with tyrosine kinase inhibitors in non-small cell lung cancer … Effectiveness and safety of "real" concurrent stereotactic radiotherapy and immunotherapy in metastatic … https://www.fda.gov/safety/reporting-serious-problems-fda/what-serious-adverse-event.